Moberg Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-27.24	-255.11	-21.09	-15.71	7.49	Upgrade
Depreciation & Amortization	1.61	1.32	2.1	2.58	2.58	Upgrade
Other Amortization	-	300	-	-	-	Upgrade
Stock-Based Compensation	5.69	4.72	2.31	1.46	0.63	Upgrade
Other Operating Activities	3.22	-65.36	-4.36	-3.8	-27.46	Upgrade
Change in Accounts Receivable	-0.85	-0.71	0.42	-0.21	6.84	Upgrade
Change in Inventory	0.72	2.82	-7.12	-	-	Upgrade
Change in Other Net Operating Assets	-0.63	-4.14	-5.46	-1.16	-4.99	Upgrade
Operating Cash Flow	-17.49	-16.47	-33.21	-16.84	-15.3	Upgrade
Cash Acquisitions	-	-	-	-	-10	Upgrade
Sale (Purchase) of Intangibles	-43.19	-73.55	-124.12	-68.07	-31.31	Upgrade
Investing Cash Flow	-43.19	-73.55	-124.12	-68.07	-41.31	Upgrade
Long-Term Debt Repaid	-1.6	-1.39	-2.43	-1.87	-3.46	Upgrade
Total Debt Repaid	-1.6	-1.39	-2.43	-1.87	-3.46	Upgrade
Net Debt Issued (Repaid)	-1.6	-1.39	-2.43	-1.87	-3.46	Upgrade
Issuance of Common Stock	0.83	335.52	100.64	109.68	133.44	Upgrade
Repurchase of Common Stock	-0.83	-	-0.19	-	-	Upgrade
Other Financing Activities	-0.07	-11.38	-5.7	-	-	Upgrade
Financing Cash Flow	-1.66	322.76	92.33	107.81	129.97	Upgrade
Net Cash Flow	-62.34	232.73	-65	22.9	73.37	Upgrade
Free Cash Flow	-17.49	-16.47	-33.21	-16.84	-15.3	Upgrade
Free Cash Flow Margin	-129.18%	-167.87%	-	-8136.23%	-	Upgrade
Free Cash Flow Per Share	-0.37	-0.43	-2.09	-2.22	-3.55	Upgrade
Cash Interest Paid	0.18	0.23	0.26	0.07	0.24	Upgrade
Levered Free Cash Flow	-54.27	27.25	-149.44	-65.28	40.32	Upgrade
Unlevered Free Cash Flow	-54.16	27.4	-149.28	-65.24	40.4	Upgrade
Change in Working Capital	-0.77	-2.03	-12.16	-1.37	1.85	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.